TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29884488

Group type: EXPERIMENTAL
Intervention: Lower leg saphenous vein composite graft
Number of subjects: 26

Group type: COMPARATOR
Intervention: Upper leg saphenous vein composite graft
Number of subjects: 26
Study: 27562731

Group type: EXPERIMENTAL
Intervention: One-night total sleep deprivation (TSD)
Number of subjects: 16

Group type: COMPARATOR
Intervention: One-night normal sleep (NS)
Number of subjects: 16
Study: 24943129

Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 50
Study: 23210360

Group type: EXPERIMENTAL
Intervention: Microcurrent reflexotherapy (MCRT) combined with cortexin therapy, massage, and remedial gymnastics
Number of subjects: 69

Group type: COMPARATOR
Intervention: Massage and remedial gymnastics alone (Control)
Number of subjects: 69
Study: 21197917

Group type: EXPERIMENTAL
Intervention: Videophone motivational interviewing diabetes self-management education (DSME) intervention
Number of subjects: 66

Group type: COMPARATOR
Intervention: Monthly videophone healthy-lifestyle education calls (Control)
Number of subjects: 66
Study: 18491100

Group type: EXPERIMENTAL
Intervention: Dual-source CT (DSCT)
Number of subjects: 12
Study: 17081398

Group type: EXPERIMENTAL
Intervention: Elevated fibrinogen (fibrinogen level > 4.0 g/L, n = 81)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control fibrinogen (fibrinogen level < or = 4.0 g/L, n = 104)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Elevated hs-CRP (hs-CRP > 3.0 mg/L, n = 86)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control hs-CRP (hs-CRP < or = 3.0 mg/L, n = 99)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Combination of elevated fibrinogen and hs-CRP
Number of subjects: 185
Study: 12681023

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) added to 2.5 g/day of metformin (MET)
Number of subjects: 550
Study: 10971048

Group type: EXPERIMENTAL
Intervention: Galantamine 16 mg/day
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/day
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Galantamine 32 mg/day
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Galantamine (pooled data from two 6-month studies, n = 1,269)
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Galantamine (for moderately severe disease)
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/day (12-month study)
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Galantamine (5-month placebo-controlled study)
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study: 8997651

Group type: EXPERIMENTAL
Intervention: 0.2% hexetidine spray
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 1546121

Group type: EXPERIMENTAL
Intervention: Moclobemide (150 mg, increased to 450 mg if necessary)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Fluvoxamine (50 mg, increased to 200 mg if necessary)
Number of subjects: 126
Study: 3979278

Group type: EXPERIMENTAL
Intervention: Flexible rectoscope
Number of subjects: 114

Group type: COMPARATOR
Intervention: Rigid rectoscope
Number of subjects: 114
Study: 31917233

Group type: EXPERIMENTAL
Intervention: Post-surgical targeted antibiotic therapy for 2 weeks
Number of subjects: 0
Study: 29328007

Group type: EXPERIMENTAL
Intervention: Intravenous hydration (0.9% NaCl)
Number of subjects: 660

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 660
Study: 26677057

Group type: EXPERIMENTAL
Intervention: Intact casein infusion
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate infusion
Number of subjects: 13
Study: 24841647

Group type: EXPERIMENTAL
Intervention: Hydrophilic resorbable film PREVADH™ applied directly to the incisions (P-Group)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Ringer's lactate solution instilled into the pelvic cavity (R-Group)
Number of subjects: 61
Study: 22643446

Group type: EXPERIMENTAL
Intervention: BI300, TiOblast‐coated fixture
Number of subjects: 10

Group type: COMPARATOR
Intervention: Previous generation, pure titanium fixture (control group)
Number of subjects: 10
Study: 20178647

Group type: EXPERIMENTAL
Intervention: Mitoxantrone, estramustine and vinorelbine (MEV)
Number of subjects: 70

Group type: COMPARATOR
Intervention: 13-cis retinoic acid (CRA), interferon-alpha2b (IFN) and paclitaxel (TAX)
Number of subjects: 70
Study: 19087330

Group type: EXPERIMENTAL
Intervention: Multidisciplinary group treatment (Go4it)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (referral to a dietician)
Number of subjects: 0
Study: 16160575

Group type: EXPERIMENTAL
Intervention: Frialit‐2 implants or IMZ Twin Plus implants
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Tobacco consumption
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Single-tooth replacement or removable prosthesis
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Serum osteocalcin, urinary pyridinoline, and deoxypyridinoline
Number of subjects: 93
Study: 11991771

Group type: EXPERIMENTAL
Intervention: MAX‐ECC
Number of subjects: 8

Group type: COMPARATOR
Intervention: 50%‐ECC
Number of subjects: 8
Study: 11329114

Group type: EXPERIMENTAL
Intervention: Calcium citrate (800 mg daily)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 7548480

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Enflurane
Number of subjects: 30
Study: 2405642

Group type: EXPERIMENTAL
Intervention: 25 micrograms arbaprostil qid for 4 weeks
Number of subjects: 630

Group type: EXPERIMENTAL
Intervention: 50 micrograms arbaprostil qid for 4 weeks
Number of subjects: 630

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 630
Study: 347110

Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thioridazine hydrochloride
Number of subjects: 30
Study: 31612630

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise with blood flow restriction (BFR)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 22
Study: 30074678

Group type: EXPERIMENTAL
Intervention: Optimistic imagery condition
Number of subjects: 45

Group type: COMPARATOR
Intervention: Neutral imagery condition
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Dispositional optimism
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Pain catastrophizing and pain expectations
Number of subjects: 45
Study: 27629597

Group type: EXPERIMENTAL
Intervention: Incredible Years (IY) parent program
Number of subjects: 341
Study: 26054119

Group type: EXPERIMENTAL
Intervention: Chlortetracycline treatment
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Chlortetracycline + beclomethasone treatment
Number of subjects: 194

Group type: COMPARATOR
Intervention: Beclomethasone treatment
Number of subjects: 194
Study: 23140198

Group type: EXPERIMENTAL
Intervention: Bone marrow examinations in ITP patients
Number of subjects: 32

Group type: COMPARATOR
Intervention: Bone marrow examinations in controls
Number of subjects: 32
Study: 20546573

Group type: EXPERIMENTAL
Intervention: Recruitment Maneuver (CPAP = 40 cm H2O for 40 s) in hypervolemic group
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Recruitment Maneuver (CPAP = 40 cm H2O for 40 s) in hypovolemic and normovolemic groups
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Hypervolemia (MAP approximately 130 mmHg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Normovolemia (MAP approximately 100 mmHg)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Hypovolemia (MAP approximately 70 mmHg)
Number of subjects: 66
Study: 18249128

Group type: EXPERIMENTAL
Intervention: Bypass surgery
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Three-vessel disease (3VD)
Number of subjects: 825
Study: 16052254

Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (PPV)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard macular photocoagulation
Number of subjects: 20
Study: 12804055

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% once daily
Number of subjects: 32
Study: 11040246

Group type: EXPERIMENTAL
Intervention: Lacidipine (4 mg once daily for 4 weeks)
Number of subjects: 10
Study: 8897117

Group type: EXPERIMENTAL
Intervention: IBM care measures
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: IBM care measures (restricted sample)
Number of subjects: 105
Study: 1801333

Group type: EXPERIMENTAL
Intervention: Oral chloroquine (nasogastric tube)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Intramuscular chloroquine (3.5 mg/kg 8-hourly)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 113
Study: 6591740

Group type: EXPERIMENTAL
Intervention: Iohexol (300 mg I/ml)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Diatrizoate (290 mg I/ml)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 51
Study: 29388884

Group type: EXPERIMENTAL
Intervention: Tweets by overweight females
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Tweets by healthy females
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Tweets by healthy weight users
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Tweets by overweight users
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Male participants
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 316
Study: 27392025

Group type: EXPERIMENTAL
Intervention: Alcohol warning advertisements
Number of subjects: 152

Group type: COMPARATOR
Intervention: Alcohol promoting advertisements
Number of subjects: 152

Group type: COMPARATOR
Intervention: Non-alcohol advertisements
Number of subjects: 152
Study: 24681813

Group type: EXPERIMENTAL
Intervention: Mobile phone technology intervention for health information exposure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple treatment framework with different variants emphasizing monetary and non-monetary benefits and costs
Number of subjects: 0
Study: 23610561

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion (5.1 mmol/kg for 24 hours)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Sodium chloride infusion (5.1 mmol/kg for 24 hours)
Number of subjects: 350
Study: 21480703

Group type: EXPERIMENTAL
Intervention: Couples' group meeting for 16 weeks focusing on couple relationship issues
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Couples' group meeting for 16 weeks focusing on parenting issues
Number of subjects: 100

Group type: COMPARATOR
Intervention: Low-dose control condition
Number of subjects: 100
Study: 18314072

Group type: EXPERIMENTAL
Intervention: Welch-Allyn SureSight autorefractor
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MTI photoscreener
Number of subjects: 100
Study: 16984383

Group type: EXPERIMENTAL
Intervention: Oral bovine lactoferrin (bLF) at a dose of 1.8 g daily for 12 weeks
Number of subjects: 199

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 199
Study: 14616447

Group type: EXPERIMENTAL
Intervention: Advanced prostate cancer patients (174 patients)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Age-matched control group (106 controls)
Number of subjects: 174
Study: 11074684

Group type: EXPERIMENTAL
Intervention: Enhanced care with manual therapy
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Enhanced care with manual therapy (four or more maneuvers)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Enhanced care alone
Number of subjects: 295
Study: 8997555

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for three days
Number of subjects: 438
Study: 1638586

Group type: EXPERIMENTAL
Intervention: Ofloxacin 200 mg daily for three days
Number of subjects: 202

Group type: COMPARATOR
Intervention: TMP/SMX 160 mg/800 mg twice daily for seven days
Number of subjects: 202
Study: 6703672

Group type: EXPERIMENTAL
Intervention: Apalcillin (2-g dose, intravenous)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Piperacillin (2-g dose, intravenous)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Apalcillin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Piperacillin
Number of subjects: 10
Study: 31406349

Group type: EXPERIMENTAL
Intervention: Biannual azithromycin distribution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 29365187

Group type: EXPERIMENTAL
Intervention: Supportive clinical practice change strategies
Number of subjects: 4

Group type: COMPARATOR
Intervention: Preintervention period
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Postintervention period
Number of subjects: 4
Study: 26561996

Group type: EXPERIMENTAL
Intervention: Plasma of argon treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Cleaning protocol by steaming (Control)
Number of subjects: 30
Study: 24299662

Group type: EXPERIMENTAL
Intervention: EGCG (300 mg/d)
Number of subjects: 83
Study: 22453114

Group type: EXPERIMENTAL
Intervention: Multi-domain cognitive training (CogTr)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Single-domain cognitive training (CogTr)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Booster training sessions (offered to 60% of initial training participants)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 270
Study: 20604801

Group type: EXPERIMENTAL
Intervention: Bet v 1 trimer (n=14)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Bet v 1 fragments (n=11)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (n=21)
Number of subjects: 46
Study: 17494794

Group type: EXPERIMENTAL
Intervention: Moli1901 (2.5 mg/d)
Number of subjects: 24
Study: 16645534

Group type: COMPARATOR
Intervention: Methyltestosterone (2.5 mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Estrogen + medroxyprogesterone + methyltestosterone
Number of subjects: 72

Group type: COMPARATOR
Intervention: Methyltestosterone only
Number of subjects: 72

Group type: COMPARATOR
Intervention: No hormone therapy (placebo)
Number of subjects: 72
Study: 12643006

Group type: EXPERIMENTAL
Intervention: Micronized sucralfate mouthwash
Number of subjects: 30

Group type: COMPARATOR
Intervention: Salt & soda mouthwash
Number of subjects: 30
Study: 10606936

Group type: EXPERIMENTAL
Intervention: FPND 400 microg twice daily (b.i.d.)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: FPND 400 microg once daily (o.d.)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: FPND 400 microg once daily (o.d.) and FPND 400 microg twice daily (b.i.d.)
Number of subjects: 142
Study: 8891846

Group type: EXPERIMENTAL
Intervention: Levosulpiride (25 mg tid)
Number of subjects: 1298

Group type: COMPARATOR
Intervention: Domperidone (10 mg tid)
Number of subjects: 1298

Group type: COMPARATOR
Intervention: Metoclopramide (10 mg tid)
Number of subjects: 1298

Group type: COMPARATOR
Intervention: Placebo (1 tablet tid)
Number of subjects: 1298
Study: 1873267

Group type: EXPERIMENTAL
Intervention: Novel method of eyedrop instillation (applied to the inner canthus with eyes tightly closed and subject supine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional instillation (into the conjunctival sac, with or without 2 min pressure on the inner canthus)
Number of subjects: 0
Study: 6359724

Group type: EXPERIMENTAL
Intervention: Aspirin 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin (50-500 mg)
Number of subjects: 0
Study: 30428707

Group type: EXPERIMENTAL
Intervention: Promoting First Relationships® (PFR) intervention
Number of subjects: 247

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 247
Study: 29189447

Group type: EXPERIMENTAL
Intervention: Peer evaluation technique during clinical skill practice sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 27587282

Group type: EXPERIMENTAL
Intervention: Allopurinol (300 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24955503

Group type: COMPARATOR
Intervention: General physical activity (GPA)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: GPA and additional strength training of the neck and shoulder (SST)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: SST
Number of subjects: 83

Group type: COMPARATOR
Intervention: GPA
Number of subjects: 83
Study: 22742765

Group type: EXPERIMENTAL
Intervention: Continuous infusion of meropenem (2 g loading dose followed by 4 g continuous infusion over 24 hours)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Bolus administration of meropenem (2 g over 30 minutes every 8 hours)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Continuous infusion of meropenem
Number of subjects: 240

Group type: COMPARATOR
Intervention: Bolus administration of meropenem
Number of subjects: 240
Study: 20152514

Group type: EXPERIMENTAL
Intervention: Population-based prostate cancer screening
Number of subjects: 0
Study: 17620552

Group type: EXPERIMENTAL
Intervention: Initial pramipexole treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: >5 systems with a comorbid illness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comorbid cardiac disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age >= 65
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mini-Mental State Examination score >28
Number of subjects: 0
Study: 15319305

Group type: EXPERIMENTAL
Intervention: Dyslexic adults
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normal-reading adults
Number of subjects: 16
Study: 11903069

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 20

Group type: COMPARATOR
Intervention: Postoperative period
Number of subjects: 20

Group type: COMPARATOR
Intervention: Postoperative 6-hydroxymelatonin sulphate excretion
Number of subjects: 20
Study: 9707656

Group type: EXPERIMENTAL
Intervention: Patient Care Travelling Record (PCTR)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no PCTR)
Number of subjects: 21
Study: 8521893

Group type: EXPERIMENTAL
Intervention: Total androgen suppression (orchiectomy plus cyproterone acetate)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Standard treatment (orchiectomy plus placebo)
Number of subjects: 294
Study: 2404429

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 392621

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 31009939

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 1066

Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILS)
Number of subjects: 1066

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1066
Study: 28295934

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg) 0.4 U/kg once daily
Number of subjects: 57

Group type: COMPARATOR
Intervention: Insulin glargine 300 U/mL (IGlar-U300) 0.4 U/kg once daily
Number of subjects: 57
Study: 26345920

Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU) therapy under nasal endoscopy guidance
Number of subjects: 120

Group type: COMPARATOR
Intervention: Corticosteroid nasal spray and oral cetirizine hydrochloride (Control)
Number of subjects: 120
Study: 23712736

Group type: EXPERIMENTAL
Intervention: Intraturbinal MAIT (group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Extraturbinal MAIT (group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Intraturbinal and Extraturbinal MAIT)
Number of subjects: 60
Study: 21311216

Group type: EXPERIMENTAL
Intervention: SPEEDA under 2-1-1 regimen (group A)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Rabipur under 2-1-1 regimen (group B)
Number of subjects: 112

Group type: COMPARATOR
Intervention: SPEEDA under Essen 5-dose regimen (group C)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 112
Study: 17459542

Group type: EXPERIMENTAL
Intervention: Having a Baby programme
Number of subjects: 170

Group type: COMPARATOR
Intervention: Regular programme
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both programmes
Number of subjects: 170
Study: 17311051

Group type: EXPERIMENTAL
Intervention: Isoflavone supplementation (70 mg/day for 24 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 15016285

Group type: EXPERIMENTAL
Intervention: Photo condition (memory cues from school class group photos)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No-photo condition
Number of subjects: 45
Study: 11282905

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 120

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 120
Study: 15321207

Group type: EXPERIMENTAL
Intervention: Supine position with 15-20 degrees right flank elevation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Left lateral position for 10 min after injection
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Left lateral position for 5 min then right lateral position for 5 min
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups (S, L, L+R)
Number of subjects: 60
Study: 7840400

Group type: EXPERIMENTAL
Intervention: 100 mg esmolol
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 200 mg esmolol
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 3048753

Group type: EXPERIMENTAL
Intervention: pH-adjusted 0.5% bupivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard commercial preparation of 0.5% bupivacaine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 1:400,000 epinephrine
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.5% bupivacaine with 1:400,000 epinephrine (control group)
Number of subjects: 100
Study: 31189618

Group type: EXPERIMENTAL
Intervention: Telotristat ethyl (TE)
Number of subjects: 369
Study: 30580350

Group type: EXPERIMENTAL
Intervention: No restriction of position (Group A)
Number of subjects: 112

Group type: COMPARATOR
Intervention: 24 hours bed rest after spinal anesthesia (Group B)
Number of subjects: 112